Issue Date: April 22, 2013
Bristol-Myers Plans Biologics Expansion
Bristol-Myers Squibb will expand its large-scale biologics manufacturing facility in Devens, Mass. The $250 million project will add biologics development and clinical trial production capabilities to the four-year-old site with separate new buildings for each operation. The firm also plans to add 350 employees. “This project represents a significant expansion in both the size and mission of Devens,” says Peter Moesta, head of biologics manufacturing and process development.
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society